Responding to booming demand for FDA-regulated, temperature-controlled storage and distribution of pharmaceutical and medical devices, Dallas-based LifeScience Logistics (LSL), a leading, national provider of healthcare supply chain solutions, today announced the company will be entering the Raleigh-Durham
Clinical logistics and life science manufacturing leaders Boston Labs and Germfree Laboratories Inc. today announced their partnership to launch a new network of mobile CGT manufacturing facilities.
Precision Coating, a leading medical coatings service provider to interventional, orthopedic, and advanced surgical markets, is pleased to announce a merger with N2 Biomedical, a Bedford, MA-based company.
Today PPC Flexible Packaging announced it has completed the first phase of a greater than $2 million facilities and equipment investment aimed at expanding and further upgrading production capacities for its Precision Clean™ cleanroom packaging business. The company purchased its Buffalo Grove based business as Fisher Container Corporation in February 2017.
“It was as long ago as 1991 when we discovered that, in many elderly people infected with HSV1, the virus is present also in the brain, and then in 1997 that it confers a strong risk of Alzheimer’s disease in the brain of people who have a specific genetic factor.”
In the maze of our brains, there are various pathways by which neural signals travel. These pathways can go awry in patients with neurological and psychiatric diseases and disorders, including epilepsy, Parkinson’s, and obsessive-compulsive disorder. Researchers have developed new therapeutic strategies to more precisely target neural pathways involved in these conditions, but they often require surgery.
Scientists from The University of Texas at Austin took an important step toward safer gene editing cures for life-threatening disorders, from cancer to HIV to Huntington’s disease, by developing a technique that can spot editing mistakes a popular tool known as CRISPR makes to an individual’s genome. The research appears today in the journal Cell.
By developing nanoparticle “backpacks” that hold immune-stimulating drugs, and attaching them directly to T cells, the MIT engineers showed in a study of mice that they could enhance those T cells’ activity without harmful side effects. In more than half of the treated animals, tumors disappeared completely.
Lumitron Technologies, Inc. Creates Breakthrough Laser-Based, X-Ray Technologies New Technology has potential to...
Biotechnology Innovation Platform Launch expected to become a national-level technology startup incubator. It aims to host at least 50 spinoff companies and commercialize the results of at least 10 HKU research projects within five years. The platform will focus on key areas including cancer treatment, medical devices and infectious disease treatment.
Realtime Flexible Sensor for Healing HKU Engineering and Medicine collaborate and develop a real-time flexible sensor...
Smart bandages designed to monitor and tailor treatment for chronic wounds Smart Bandages with integrated pH and...